Extrait

Background and study aims Thoracic surgery includes operations on all parts of the chest including the chest wall, the contents of the chest and the lungs, except for heart surgery. A thoracotomy is a surgical incision (cut) into the chest wall to open the chest cavity. Post-thoracotomy pain is felt in the back and chest region after a thoracotomy. The aim of this study is to find out whether dexmedetomidine plus local anesthetic Levobupivacaine could extend pain relief time compared with Levobupivacaine alone at the end of thoracic surgery. Who can participate? Patients aged 20-60 undergoing elective thoracic surgery What does the study involve? Participants are randomly allocated to one of two groups. One group receive levobupivacaine and the other group receive levobupivacaine plus dexmedetomidine. Participants’ pain, opioid (pain relief) consumption and adverse effects are monitored. What are the possible benefits and risks of participating? The results of this study will help to confirm the best method of pain relief and the patient may benefit from pain relief. No risks are expected. Where is the study run from? National Cancer Institute, Cairo University (Egypt) When is the study starting and how long is it expected to run for? March to September 2017 Who is funding the study? National Cancer Institute, Cairo University (Egypt) Who is the main contact? Dr Ahmed Bakir [email protected]

Critère d'inclusion

• Post Thoracotomy Pain

Liens

• isrctn